한방비만학회지 (Journal of Korean Medicine for Obesity Research)

  • 제24권1호
  • /
  • Pages.76-86
  • /
  • 2024
  • /
  • 1976-9334(pISSN)
  • /
  • 2288-1522(eISSN)
한방비만학회 (The Society of Korean Medicine for obesity Research)
권호 표지
DOI QR코드

DOI QR Code

과체중 및 비만 환자의 복약기간에 따른 치료효과 및 안전성의 상관관계: 후향적 분석

A Study on Correlation between Anti-Obesity Effect and Safety According to Medication Period of Korean Medicine in Overweight and Obese Patients: A Retrospective Analysis

  • 최현 (경희아이한의원 성동점) ;
  • 남정훈 (자연과한의원 신림점) ;
  • 이혁재 (자연과한의원 강남점) ;
  • 서기성 (로하셀한의원)
  • Hyeon Choi (KyungHee-I Clinic of Korean Medicine) ;
  • Jung-Hun Nam (Sillim NATURAL & Oriental Medicine Clinic) ;
  • Hyuk-Jae Lee (Gangnam NATURAL & Oriental Medicine Clinic) ;
  • Ki-Seong Seo (LOHACELL Oriental Medicine Clinic)
  • 투고 : 2024.05.04
  • 심사 : 2024.06.08
  • 발행 : 2024.06.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objectives: This retrospective study attempted to determine whether the treatment effect improves as the longer the medication for obese patients, also, analyzed whether the long medication increases the burden on liver function. Methods: The subjects were 278 overweight and obese female patients who took the herbal medicine Jibangsayak (JBSY) for more than 15 days. The correlation between the duration of medication and the treatment effect was confirmed, and the correlation with the safety was also analyzed. Results: JBSY significantly reduced all obesity-related measures after treatment. All these valuables before treatment were not factors in determining the duration of medication. As the duration increased, the body mass index (BMI) improvement decreased and lean body and muscle mass increased. As the duration was closer to 60 days, BMI improvement increased, and in more than 90 days group, the BMI and body fat percentage improvement stagnated as the duration longer. Aspartate aminotransferase (AST), alanine aminotransferase, and gamma-glutamyl transferase decreased after treatment. Additionally, AST decreased as the duration increased. Conclusions: This result suggests that not only the high obesity-related measures at first visit not lengthen the duration of JBSY medication. And liver function levels did not worsen as the duration increased. This result is different from the general perception that the longer the duration of medication, the greater the burden on patient's drug metabolism. However, the fact that other factors that could affect liver function could not be excluded and that kidney function evaluation should have been performed simultaneously are limitations of this study and require more detailed research in the future.

키워드

참고문헌

  1. Sutin AR, Zonderman AB. Depressive symptoms are associated with weight gain among women. Psychol Med. 2012 ; 42(11) : 2351-60. 
  2. Lord SR, Murray SM, Chapman K, Munro B, Tiedemann A. Sit-to-stand performance depends on sensation, speed, balance, and psychological status in addition to strength in older people. J Geront ol A Biol Sci Med Sci. 2002 ; 57(8) : M539-43. 
  3. Rock CL, Doyle C, Demark-Wahnefried W, Meyerhardt J, Courneya KS, Schwartz AL, et al. Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin. 2012 ; 62(4) : 243-74. 
  4. Da Fonseca AM, Bagnoli VR, Souza MA, Azevedo RS, Couto Ede B Jr, Soares JM Jr, et al. Impact of age and body mass on the intensity of menopausal symptoms in 5968 Brazilian women. Gynecol Endocrinol. 2013 ; 29(2) : 116-8. 
  5. Seoul Economics. Obesity to undermine future Korea [Internet]. 2018 [cited 2024 Jan 15]. https://www.sedaily.com/NewsView/1S5TJVPVBI 
  6. Lakka HM, Lakka TA, Tuomilehto J, Salonen JT. Abdominal obesity is associated with increased risk of acute coronary events in men. Eur Heart J. 2002 ; 23(9) : 706-13. 
  7. Fontaine KR, Barofsky I. Obesity and health-related quality of life. Obes Rev. 2001 ; 2(3) : 173-82. 
  8. Shin JH, Yoon YS, Yang YJ, Lee ES, Lee JH, Kwak HL, et al. The relationship between obesity and health-related quality of life in Koreans. Korean J Fam Pract. 2011 ; 1(2) : 101-10. 
  9. Jung DY. A st udy on t he level of int erest and st at us of women's obesity care [Master's thesis]. Hansung University; 2015. 
  10. Kim HJ, Han CJ. Investigation and analysis of obesity treatment and obesity management behavior in Korean medicine clinics. J Kor Soc Cosmetol. 2022 ; 28(6) : 1292-307. 
  11. Han K, Lee MJ, Kim H. Systematic review on herbal treatment for obesity in adults. J Korean Med Rehabil. 2016 ; 26(4) : 23-35. 
  12. Heo JK, Hwang DS, Lee CH, Lee KS. A case study on a non-alcoholic fatty liver disease (NAFLD) patient improved by the oriental obesity therapy program. J Korean Med Obes Res. 2007 ; 7(2) : 85-94. 
  13. Lee JH, Jeon WH. Effects of the obesity therapy with Korean herbal medicine on liver function: case series. J Korean Med Obes Res. 2017 ; 17(1) : 54-60. 
  14. Kim BY, Kang SM, Kang JH, Kang SY, Kim KK, Kim KB, et al. 2020 Korean society for the study of obesity guidelines for the management of obesity in Korea. J Obes Metab Syndr. 2021 ; 30(2) : 81-92. 
  15. Gallagher D, Heymsfield SB, Heo M, Jebb SA, Murgatroyd PR, Sakamoto Y. Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index. Am J Clin Nutr. 2000 ; 72(3) : 694-701. 
  16. Wardle J, Haase AM, Steptoe A. Body image and weight control in young adults: international comparisons in university students from 22 countries. Int J Obes (Lond). 2006 ; 30(4) : 644-51. 
  17. Jeong MR, Chang BS. A study on recognition and management of obesity of adult women. Asia-Pac J Multimed Serv Converg Art Humanit Sociol. 2016 ; 6(9) : 505-17. 
  18. Noh JW, Kwon YD, Yang Y, Cheon J, Kim J. Relationship between body image and weight status in east Asian countries: comparison between South Korea and Taiwan. BMC Public Health. 2018 ; 18(1) : 814. 
  19. Cho HS, Seo Y, Kim KW, Cho JH, Song MY. The retrospective analysis of effects of H Gambitang (GB-001) on weight loss in pre- and post-menopausal obese woman. J Korean Med Obes Res. 2020 ; 20(1) : 20-30. 
  20. Yoon SH, Lee E, Jo H, Han Y, Kim H, Yun Y, et al. Effect and safety of combined treatment of Gambihwan and Garcinia Cambogia on weight loss: a retrospective observational study. J Korean Med Obes Res. 2020 ; 20(1) : 31-9. 
  21. Choi EM, Ryu EK. Effects of Bang-pung-tong-seoungsan on obese patients. J Korean Med Obes Res. 2001 ; 1(1) : 1-11. 
  22. Shin WY, Seo GS, Song JH, Baek CH. The ret rospective analysis on obese and overweight female patients with Korean medical treatment and its effectiveness for clinical setting of seasonal treatment. J Korean Med Obes Res. 2017 ; 17(1) : 10-9. 
  23. Bae JH, Chung SH, Lee JS, Kim SS, Shin HD. Clinical study on the efficacy of Yanghae (Bangpungtongseoungsan) in the treatment of obesity. J Orient Rehab Med. 2003 ; 13(1) : 37-46. 
  24. Lim Y, Min S, Kim H, Hur KW, Lee H, Lee J, et al. Comparisons of effects of Biman-tang according to administration period in childhood obesity. J Pediatr Korean Med. 2013 ; 27(4) : 57-67. 
  25. Seo HY. Comparative study of obesity pharmacotherapy in Korea and evidence based therapy [Master's thesis]. Sungkyunkwan University; 2020. 
  26. Yang J, Sung D, Kim EG, Lee S. Effects of long-term intake of Korean medicine on gynecology patients' livers and kidneys; panel study. J Korean Med. 2020 ; 41(1) : 84-92. 
  27. Kim DW. The change of renal function in diabetic nephropathy and chronic renal failure patients with long term herb medication by frequently prescribed formular. Korean J Oriental Physiol Pathol. 2004 ; 18(4) : 1207-12.